Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum

Author： Schoennemann Katrine  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.14, Iss.3, 2011-08, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

By Koizumi Tomonobu   Yoshiike Fumiaki   Inou Hitoshi   Hatayama Orie   Sasabayashi Mari   Tsushima Kenji   Yamamoto Hiroshi   Hayasaka Muneharu   Kubo Keishi  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 133-138

Humana Press, Inc

Access to resources Recommend Favorite

Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer

By Kanai Masashi   Matsumoto Shigemi   Nishimura Takahumi   Shimada Yutaka   Watanabe Go   Kitano Toshiyuki   Misawa Akiko   Ishiguro Hiroshi   Yoshikawa Kiyotsugu   Yanagihara Kazuhiro   Teramukai Satoshi   Mitsumori Michihide   Chiba Tsutomu   Sakai Yoshiharu   Fukushima Masanori  

International Journal of Clinical Oncology, Vol. 12, Iss. 3, 2007-06 ,pp. : 224-227

Springer Publishing Company

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

By Kosmas Christos   Tsavaris Nicolas   Syrigos Konstantinos   Koutras Angelos   Tsakonas George   Makatsoris Thomas   Mylonakis Nicolas   Karabelis Athanasios   Stathopoulos George   Kalofonos Haralambos  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil

By Pfeiffer Per   Nielsen Dorte   Yilmaz Mette   Iversen Anja   Vejlø Christian   Jensen Benny Vittrup  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 697-701

Informa Healthcare

Access to resources Recommend Favorite